Articles producció científica> Bioquímica i Biotecnologia

The microbiota–gut–brain axis in obesity

  • Identification data

    Identifier: imarina:6389273
    Authors:
    Torres-Fuentes, CSchellekens, HDinan, TGCryan, JF
    Abstract:
    © 2017 Elsevier Ltd Changes in microbial diversity and composition are increasingly associated with several disease states including obesity and behavioural disorders. Obesity-associated microbiota alter host energy harvesting, insulin resistance, inflammation, and fat deposition. Additionally, intestinal microbiota can regulate metabolism, adiposity, homoeostasis, and energy balance as well as central appetite and food reward signalling, which together have crucial roles in obesity. Moreover, some strains of bacteria and their metabolites might target the brain directly via vagal stimulation or indirectly through immune-neuroendocrine mechanisms. Therefore, the gut microbiota is becoming a target for new anti-obesity therapies. Further investigations are needed to elucidate the intricate gut-microbiota–host relationship and the potential of gut-microbiota-targeted strategies, such as dietary interventions and faecal microbiota transplantation, as promising metabolic therapies that help patients to maintain a healthy weight throughout life.
  • Others:

    Author, as appears in the article.: Torres-Fuentes, C; Schellekens, H; Dinan, TG; Cryan, JF
    Department: Bioquímica i Biotecnologia
    URV's Author/s: Torres Fuentes, Cristina
    Abstract: © 2017 Elsevier Ltd Changes in microbial diversity and composition are increasingly associated with several disease states including obesity and behavioural disorders. Obesity-associated microbiota alter host energy harvesting, insulin resistance, inflammation, and fat deposition. Additionally, intestinal microbiota can regulate metabolism, adiposity, homoeostasis, and energy balance as well as central appetite and food reward signalling, which together have crucial roles in obesity. Moreover, some strains of bacteria and their metabolites might target the brain directly via vagal stimulation or indirectly through immune-neuroendocrine mechanisms. Therefore, the gut microbiota is becoming a target for new anti-obesity therapies. Further investigations are needed to elucidate the intricate gut-microbiota–host relationship and the potential of gut-microbiota-targeted strategies, such as dietary interventions and faecal microbiota transplantation, as promising metabolic therapies that help patients to maintain a healthy weight throughout life.
    Thematic Areas: Hepatology Gastroenterology & hepatology Gastroenterology
    licence for use: https://creativecommons.org/licenses/by/3.0/es/
    ISSN: 24681253
    Author's mail: cristina.torres@urv.cat
    Author identifier: 0000-0002-2917-6910
    Record's date: 2024-09-07
    Papper version: info:eu-repo/semantics/submittedVersion
    Link to the original source: https://www.sciencedirect.com/science/article/abs/pii/S2468125317301474
    Licence document URL: https://repositori.urv.cat/ca/proteccio-de-dades/
    Papper original source: Lancet Gastroenterology & Hepatology. 2 (10): 747-756
    APA: Torres-Fuentes, C; Schellekens, H; Dinan, TG; Cryan, JF (2017). The microbiota–gut–brain axis in obesity. Lancet Gastroenterology & Hepatology, 2(10), 747-756. DOI: 10.1016/S2468-1253(17)30147-4
    Article's DOI: 10.1016/S2468-1253(17)30147-4
    Entity: Universitat Rovira i Virgili
    Journal publication year: 2017
    Publication Type: Journal Publications
  • Keywords:

    Gastroenterology,Gastroenterology & Hepatology,Hepatology
    Hepatology
    Gastroenterology & hepatology
    Gastroenterology
  • Documents:

  • Cerca a google

    Search to google scholar